Evidera, a PPD business, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products. We help companies generate the evidence needed to optimize the market access and commercial potential of their products.  We provide integrated and tailored scientific expertise and global operational capabilities. Our offerings include interventional studies, real-world evidence, data analytics, patient-centered research, epidemiological studies, modeling and simulation, literature reviews and evidence synthesis, market access consulting and communications, and medical writing.

Evidera has approximately 750 employees, including epidemiologists, health economists, outcomes researchers, market access consultants, and operational staff, representing over 45 nationalities in locations around the world. Our scientific and consulting staff are methodological and thought leaders who have contributed to hundreds of submissions to payers and regulators and have published more than 2,400 peer-reviewed articles dating back over 30 years.